Abstract
In this work we employed quantum biochemistry methods based on the density functional theory (DFT) model and the MFCC (Molecular Fractionation with Conjugate Caps) scheme to unveil the detailed binding energy features of the tissue-selective synthetic agents SERMs (selective estrogen receptor modulators) 4-hydroxytamoxifen (OHT) and raloxifene (RAL), widely used in the breast cancer treatment, co-crystallized with the estrogen receptor α (ERα). Our theoretical/computational results demonstrated that the total binding energies of OHT and RAL to the ERα ligand-pocket correlate with the experimental binding affinity. Besides, we found that SERMs-OHT binds stronger when compared to SERMs-RAL, confirming experimental data, whose main contributions to the total SERMs-ERα binding energy are due to the amino acid residues in decreasing sequence D351>E542>D538>E353>E423, an important information to understand their binding mechanisms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
